Doubling progression-free survival (17.6 vs 7.4 months) is a large effect size for recurrent prostate cancer.
I’m pretty sure Linux doesn’t have a prostate, even with all the changes in the leading edge distros, and you’re commenting in the wrong post.
alt Hacker News
I’m pretty sure Linux doesn’t have a prostate, even with all the changes in the leading edge distros, and you’re commenting in the wrong post.